Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-05-22 @ 2:07 PM
Study NCT ID:
NCT02110992
Status:
TERMINATED
Last Update Posted:
2019-11-25
First Post:
2014-04-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
Sponsor:
University of Cincinnati
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords: